Valuation: Avantor, Inc.

Market Cap 10.18B 9.04B 8.46B 7.7B 14.51B 980B 14.7B 102B 39.6B 499B 38.22B 37.39B 1,603B P/E 2026 *
45x
P/E 2027 * 32.3x
Enterprise Value 13.24B 11.76B 11B 10.02B 18.87B 1,275B 19.13B 133B 51.51B 649B 49.72B 48.64B 2,086B EV / Sales 2026 *
2.01x
EV / Sales 2027 * 1.87x
Free-Float
95.47%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 18/08/2025
Director of Finance/CFO 57 21/09/2026
Chief Operating Officer - 10/11/2025
Director TitleAgeSince
Director/Board Member 60 22/04/2020
Chairman 69 01/01/2026
Director/Board Member 62 01/10/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%-2.93% - - 10.18B
-1.64%-3.51%-26.93%+1.88% 171B
+0.32%-2.20%-8.70%+11.30% 110B
-0.53%+1.43%-24.87%-0.09% 106B
-0.69%-0.07%-47.78%-11.65% 75.99B
+3.34%-0.02%-0.63%+73.00% 57.3B
-0.12%-0.36%-6.47%-30.72% 48.76B
+3.44%+7.90%+19.12%+59.15% 50.19B
-0.19%+1.34%-16.10%+20.72% 41.14B
+0.30%-1.37%+30.56%-8.75% 32.56B
Average +0.54%-1.46%-9.09%+12.76% 77B
Weighted average by Cap. +0.08%-2.07%-15.71%+9.95%

Financials

2026 *2027 *
Net sales 6.59B 5.86B 5.48B 4.99B 9.39B 635B 9.52B 66.25B 25.65B 323B 24.75B 24.22B 1,038B 6.74B 5.99B 5.6B 5.1B 9.61B 649B 9.74B 67.76B 26.23B 331B 25.32B 24.77B 1,062B
Net income 225M 200M 187M 170M 321M 21.68B 325M 2.26B 876M 11.04B 845M 827M 35.46B 311M 276M 258M 235M 443M 29.92B 449M 3.12B 1.21B 15.24B 1.17B 1.14B 48.95B
Net Debt 3.06B 2.72B 2.54B 2.32B 4.37B 295B 4.43B 30.78B 11.92B 150B 11.5B 11.25B 482B 2.42B 2.15B 2.01B 1.83B 3.45B 233B 3.5B 24.35B 9.42B 119B 9.1B 8.9B 382B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company's segments include Bioscience & Medtech Products and VWR Distribution & Services. Through these segments, it provides materials and consumables, equipment and instrumentation and services and specialty procurement to customers in biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and others.
Employees
13,500
Trader
Investor
Global
Quality
ESG MSCI
-